Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/1996
06/19/1996EP0563134B1 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
06/19/1996EP0489089B1 Therapeutic peptides
06/19/1996CN1124921A Compositions for boron neutron capture therapy and methods thereof
06/18/1996US5527890 Derivatives of triterpenoid acids and uses thereof
06/18/1996US5527805 Dna-cleaving, cytotoxic and anti-tumor compounds
06/18/1996US5527803 Immunosuppressants, phosphorylase inhibitors
06/18/1996US5527789 Administering a ubiquinone to combat heart failure
06/18/1996US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF
06/18/1996CA2020878C Antitumor antibiotic bu-3285t
06/15/1996CA2164916A1 Vitamin d compounds and method of preparing these compounds
06/13/1996WO1996017931A1 Human vascular ibp-like growth factor
06/13/1996WO1996017925A1 Cytokine designated lerk-7
06/13/1996WO1996017866A1 Novel protein domain which binds tyrosine phosphorylated proteins
06/13/1996WO1996017863A1 Induction of cytotoxic t-lymphocyte responses
06/13/1996WO1996017861A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
06/13/1996WO1996017856A1 Synthesis of bidentate phosphines
06/13/1996WO1996017855A1 Anti-tumour agents
06/13/1996WO1996017845A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996WO1996006620A3 Lipid analogs for treating viral infections
06/13/1996CA2207299A1 Anti-tumour agents
06/13/1996CA2206965A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996CA2206488A1 Cytokine designated lerk-7
06/13/1996CA2204738A1 Induction of cytotoxic t-lymphocyte responses
06/13/1996CA2204144A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
06/12/1996EP0716148A2 Recombinant alphavirus vectors
06/12/1996EP0716085A1 Amino acid derivatives of paclitaxel
06/12/1996EP0715854A2 Carcinostatic compositions containing cis-oxalato and one or more other compatible carcinostatic substances
06/12/1996EP0715632A1 Anti-sense oligonucleotides for aromatase inhibition
06/12/1996EP0715628A1 Substituted azaindolylidene compounds and process for their preparation
06/12/1996EP0715624A1 Process for the preparation of benzodiazepine compounds useful as antagonists of cck or of gastrine
06/12/1996EP0715613A1 New diphenylhexene
06/12/1996EP0715523A1 Purine nucleoside phosphorylase gene therapy for human malignancy
06/12/1996EP0618901B1 Highly water soluble bis-naphthalimides useful as anticancer agents
06/12/1996EP0498843B1 Oligonucleotide analogs with novel linkages
06/12/1996CN1124501A Anti-EGFR single-chain Fvs and anti-EGFR antibodies
06/12/1996CN1124491A Inhibitor of stem cell proliferation and uses thereof
06/12/1996CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products
06/12/1996CN1124251A Aza steroid preparation and its use
06/12/1996CN1124142A Oligonucleotides to inhibit the expression of isoprenyl protein transferases
06/12/1996CN1032019C Process for recombinant biocides using organisms
06/11/1996US5525632 Stilbene derivatives and pharmaceutical compositions containing them
06/11/1996US5525629 Inhibition of cytokine production
06/11/1996US5525625 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders
06/11/1996US5525611 Antitumor agent, bactericides, viricides
06/11/1996US5525609 Alkaloids from Mappia foetida, the use thereof and formulations containing them
06/11/1996US5525606 Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
06/11/1996US5525602 Method of using 4-amino 6-substituted mycophenolic acid and derivatives
06/11/1996US5525598 Viricides or antitumor agents
06/11/1996US5525594 Administering a plant extract oenotheine b to inhibit 5 alpha-reductase
06/11/1996US5525590 Immunosuppressants, antiinflammatory and antiparasitic
06/11/1996US5525513 Isolated mammalian dna sequence which hybridizes to specified primers
06/11/1996US5525486 Genetic engineering
06/11/1996US5525338 Detection and therapy of lesions with biotin/avidin conjugates
06/11/1996US5525337 Detecting tumor cells by removing tissue or fluid sample, reacting with antibody capable of binding to surface antigen, detecting presence of antibody-antigen complex
06/11/1996US5525325 Form metal complexes active as photosensitizers which are stable and water soluble
06/11/1996EP0722489A4 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
06/11/1996CA1338381C Minactivin - (plasminogen activator inhibitor-2)
06/06/1996WO1996017063A1 Plasmids suitable for il-2 expression
06/06/1996WO1996017053A1 Vectors for tissue-specific replication
06/06/1996WO1996016990A1 Humanized antibodies to cd38
06/06/1996WO1996016988A1 Reagents and processes for targeting mutant epidermal growth factor receptors
06/06/1996WO1996016976A1 Antisense oligonucleotide and carcinostatic agent containing the same
06/06/1996WO1996016967A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/06/1996WO1996016966A1 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
06/06/1996WO1996016964A1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
06/06/1996WO1996016960A1 Quinazoline derivatives
06/06/1996WO1996016931A1 Metalloproteinase inhibitors
06/06/1996WO1996016676A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors
06/06/1996WO1996016664A1 Compositions for the treatment of parasitic and fungal infections
06/06/1996CA2206511A1 Compositions for the treatment of parasitic and fungal infections
06/06/1996CA2206205A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors
06/06/1996CA2205972A1 Metalloproteinase inhibitors
06/06/1996CA2205577A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/05/1996EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands
06/05/1996EP0714911A2 Somastotatin analogs containing chelating groups and their radiolabeled compositions
06/05/1996EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors
06/05/1996EP0714449A1 Oligonucleotide modulation of protein kinase c
06/05/1996EP0714410A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents
06/05/1996EP0714390A1 Indole derivatives as 5-alpha-reductase-1-inhibitors
06/05/1996EP0714387A1 New bis-naphthalimides for the treatment of cancer
06/05/1996EP0714304A1 Therapeutic system for treating psoriasis
06/05/1996EP0714298A1 Photosensitizers
06/05/1996EP0714291A1 Lupane triterpenoid derivatives
06/05/1996CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy
06/05/1996CN1124012A Arylating medicaments
06/05/1996CN1123658A Foot bathing lotion for eliminating tumor
06/04/1996US5523490 Antitumor agents
06/04/1996US5523457 Used for preventing or treating skin disorders like acne, psoriasis, damage for irradiation; antitumor agent
06/04/1996US5523456 Anticarcinogenic agents
06/04/1996US5523389 Inhibitors of human immunodeficiency virus
06/04/1996US5523320 For treatment of leukemia
06/04/1996US5523309 Benzofuran pharmaceutical compounds
06/04/1996US5523304 Reversal of multi-drug resistance by tetraarylethylenes
06/04/1996US5523085 Monoclonal antibody in destruction of small cell lung carcinoma
06/04/1996EP0722440A4 Pyrimidinyl-glutamic acid derivatives
05/1996
05/30/1996WO1996016179A1 Enzyme gene therapy catalysing prodrug extracellular conversion
05/30/1996WO1996016176A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
05/30/1996WO1996016170A2 Proteins involved in the regulation of cell-cell adhesion and uses thereof
05/30/1996WO1996016169A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
05/30/1996WO1996016068A1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
1 ... 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 ... 2211